Table 2 Factors associated with lipid control among patients with T2DM (Multiple logistic regression model)

Sex

 Male

1,045 (80.26)

257 (19.74)

Ref

 Female

1,436 (81.68)

322 (18.32)

1.28 (0.63, 1.95)

0.150

Age^a (years), mean (SD)

43.55 (13.54)

49.77 (11.13)

0.97 (0.96, 0.98)

< 0.001

BMI category

 Underweight

4 (66.67)

2 (33.33)

Ref

 Normal

136 (70.10)

58 (29.90)

0.75 (0.10, 4.18)

0.8

 Overweight

932 (86.54)

145 (13.46)

1.04 (0.14, 5.71)

> 0.9

 Obese

1,409 (79.02)

374 (20.98)

0.79 (0.10, 4.34)

0.8

Duration of diabetes category

 Up to 5 years

1,691 (86.54)

263 (13.46)

Ref

 5–10 years

491 (73.83)

174 (26.17)

0.64 (0.49, 0.82)

< 0.001

 > 10 years

299 (67.80)

142 (32.20)

0.53 (0.39, 0.72)

< 0.001

Diabetes medication

 No drug

237 (71.60)

94 (28.40)

Ref

 OHA

1,242 (82.52)

263 (17.48)

1.65 (1.21, 2.23)

0.001

 OHA + Insulin

1,002 (81.86)

222 (18.14)

2.01 (1.45, 2.77)

< 0.001

Cardiovascular comorbidity

 No

177.00 (54.46)

148.00 (45.54)

Ref

 Yes

2,304 (84.24)

431 (15.76)

3.92 (3.00, 5.12)

< 0.001

According to HbA1c level

 < 7%

226 (73.62)

81 (26.38)

Ref

 ≥ 7%

2255 (81.91)

498 (18.19)

1.12 (0.82, 1.54)

0.502

Lipid lowering therapy

 Moderate intensity statin

2,414 (82.73)

504 (17.27)

Ref

 High-intensity statin

17 (73.91)

6 (26.09)

1.05 (0.42, 3.02)

> 0.9

 Non-statin (Fenofibrate)

50 (42.02)

69 (57.98)

0.25 (0.16, 0.37)

< 0.001